Skip to main content
Colgate-Palmolive (India) Ltd. logo

Colgate-Palmolive (India) Ltd. — Investor Relations & Filings

Ticker · COLPAL ISIN · INE259A01022 LEI · 335800YWKI47DGFKWB26 BSE.NS Manufacturing
Open in API
Filings indexed 2,108 across all filing types
Latest filing 2026-05-22 Report Publication Anno…
Country IN India
Listing BSE.NS COLPAL

About Colgate-Palmolive (India) Ltd.

https://www.colgatepalmolive.co.in/

Colgate-Palmolive (India) Ltd. specializes in the manufacturing and distribution of oral and personal care products. The company offers a comprehensive range of oral hygiene solutions, including toothpastes, toothbrushes, and mouthwashes under the Colgate brand, catering to diverse consumer needs such as cavity protection, gum health, and whitening. Its personal care segment features liquid hand washes and body washes under the Palmolive brand. The organization emphasizes research and development to drive product innovation and maintains an extensive distribution network to ensure product accessibility. It also engages in community-based oral health programs and prioritizes sustainable manufacturing practices and resource efficiency across its operations.

Recent filings

Filing Released Lang Actions
Please find eclosed the Press Release.
Report Publication Announcement Classification · 78% confidence The document is a stock‐exchange filing under SEBI Listing Regulations providing the “Outcome of the Board Meeting” – notably approving and attaching the audited quarterly and year‐end financial results (with the auditors’ report), declaring an interim dividend, fixing the AGM, and re‐appointing a director. Although it contains an audit report excerpt, the primary function is to announce the publication of those reports and related corporate actions, rather than presenting the full financial statements themselves. This matches our “Report Publication Announcement” (RPA) category.
2026-05-22 English
Please find enclosed the date of 85th AGM
Interim / Quarterly Report Classification · 84% confidence The document is the formal “Outcome of the Board Meeting” under SEBI Listing Regulations, which (1) approves and encloses the audited financial results for the quarter and full year ended March 31, 2026, including complete statements and the Independent Auditor’s Report, (2) declares an interim dividend, and (3) sets AGM details and a senior management appointment. It is not merely an announcement of publication (it contains the full audited financials and audit opinion), nor is it a short earnings highlight. Rather, it provides comprehensive financial statements for the quarter (Q4) and year‐to‐date, satisfying the criteria for an Interim/Quarterly Report (IR) since it contains substantive financial data beyond simple highlights. FY 2026
2026-05-22 English
Change in Management
Regulatory Filings Classification · 85% confidence The document is a formal notice to BSE and NSE under SEBI Listing Regulations reporting the outcomes of a Board meeting: approval of audited financial results for Q4 and full year, declaration of an interim dividend, AGM convening details, and a director re-appointment. Although it includes an Independent Auditor’s Report and references attached financial statements, it is not the full annual report nor a standalone quarterly/half-year report; rather it is a regulatory filing announcing Board resolutions and result attachments. There is no dedicated “Board Meeting Outcome” category, so it falls under the general Regulatory Filings (RNS) category.
2026-05-22 English
Please find enclosed change in management
Regulatory Filings Classification · 90% confidence The document is a statutory disclosure filed under SEBI Listing Regulations reporting the outcome of a board meeting: audited financial results for Q4 and year ended March 31, 2026 (including the auditor’s report and full financial statements), declaration of an interim dividend, AGM scheduling, and the re-appointment of the CFO. It is not the company’s full annual report (10-K), nor a standalone audit report (AR), earnings release (ER) or investor presentation (IP). Rather, it is a routine regulatory announcement to exchanges with multiple corporate actions. Therefore it best fits our fallback category for miscellaneous regulatory filings (RNS).
2026-05-22 English
Please find below Interim Dividend Updates.
Regulatory Filings Classification · 85% confidence The document is a formal stock‐exchange disclosure under SEBI Listing Regulation 30 announcing the outcome of a Board meeting, including the approval of audited financial results, declaration of an interim dividend, scheduling of the AGM, and reappointment of a director. While it attaches audit reports and financial statements, it is fundamentally a regulatory announcement rather than the standalone full annual report, earnings press release, or dedicated management discussion. It does not fit neatly into any specific category such as ER or IR and is best treated as a general regulatory filing.
2026-05-22 English
Record Date
Regulatory Filings Classification · 82% confidence The document is an official SEBI Listing Regulations disclosure titled “Outcome of the Board Meeting,” filed to the BSE and NSE. It reports the board’s approval of audited quarterly and full‐year financial results, declares an interim dividend, sets the AGM date, and details a CFO reappointment. It is not the full Annual Report (10-K), nor a pure earnings highlight (ER), nor a standalone proxy or AGM pack. It is a composite regulatory announcement under Reg. 30, serving as a general listing‐obligation filing. Thus, it best fits the “Regulatory Filings” (RNS) category.
2026-05-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.